GlaxoSmithKline (GSK) has released an update.
GlaxoSmithKline plc has announced the transfer of 27.8 million treasury shares to JPMorgan Chase Bank to facilitate the issuance of 13.9 million American depositary receipts, supporting the company’s employee incentive plans. The transaction, priced at $41.93 per ADR, affected the company’s total number of voting rights, which now stands at 4,144,879,946. This financial move is integral for shareholders tracking changes in company interests under the Financial Conduct Authority’s guidelines.
For further insights into GSK stock, check out TipRanks’ Stock Analysis page.
